Cite
HARVARD Citation
Wagen, L. et al. (2018). Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib. Bone marrow transplantation. pp. 1255-1262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wagen, L. et al. (2018). Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib. Bone marrow transplantation. pp. 1255-1262. [Online].